Clinical Trial Details

Trial ID: L0640
Source ID: IRCT2013060411763N8
Associated Drug: Vitamin D
Title: Effect of vitamin D supplementation on inflammatory markers, liver function, lipid profile, body composition, and sonographic findings in patients with NAFLD
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non alcohlic fatty liver disease. <br>Other diseases of liver;Other diseases of liver
Interventions: Intervention 1: This randomized clinical trial will be conducted in parallel. The objective of this study is the low number of participants in this study, 60 patients with NAFLD are referred to the Medical Research Center for Gastroenterology.The consent
Outcome Measures: The severity of fatty liver using abdominal ultrasound at baseline and end of study. Timepoint: Baseline and 10 weeks after intervention. Method of measurement: ultrasound.;AST and ALT liver enzymes. Timepoint: Baseline and 10 weeks after intervention. Method of measurement: Blood tests.Body composition. Timepoint: baseline and 10 weeks after intervention. Method of measurement: instrument body composition.;FBS. Timepoint: baseline and 10 weeks after intervention. Method of measurement: blood test.;Lipid profile. Timepoint: baseline and 10 weeks after intervention. Method of measurement: blood test.;CRP. Timepoint: baseline and 10 weeks after intervention. Method of measurement: blood test.
Sponsor/Collaborators: Food Security Research Center
Gender: All
Age: no limitno limit
Phases: Not applicable
Enrollment: 60
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 12/09/2013
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/11921